1. Home
  2. AGCC vs STXS Comparison

AGCC vs STXS Comparison

Compare AGCC & STXS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

AGCC

Agencia Comercial Spirits Ltd Class A Ordinary Shares

N/A

Current Price

$11.17

Market Cap

209.9M

ML Signal

N/A

Logo Stereotaxis Inc.

STXS

Stereotaxis Inc.

HOLD

Current Price

$1.99

Market Cap

210.0M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
AGCC
STXS
Founded
2020
1990
Country
Taiwan
United States
Employees
N/A
N/A
Industry
Beverages (Production/Distribution)
Biotechnology: Electromedical & Electrotherapeutic Apparatus
Sector
Consumer Staples
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
209.9M
210.0M
IPO Year
2025
2004

Fundamental Metrics

Financial Performance
Metric
AGCC
STXS
Price
$11.17
$1.99
Analyst Decision
Strong Buy
Analyst Count
0
2
Target Price
N/A
$4.00
AVG Volume (30 Days)
80.7K
494.1K
Earning Date
02-27-2026
03-09-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
0.06
N/A
Revenue
$3,038,946.00
$30,075,000.00
Revenue This Year
N/A
$24.21
Revenue Next Year
N/A
$29.83
P/E Ratio
$197.94
N/A
Revenue Growth
186.00
19.62
52 Week Low
$3.66
$1.54
52 Week High
$14.72
$3.59

Technical Indicators

Market Signals
Indicator
AGCC
STXS
Relative Strength Index (RSI) 67.86 32.35
Support Level $9.05 $1.97
Resistance Level $12.62 $2.16
Average True Range (ATR) 1.41 0.12
MACD 0.28 -0.03
Stochastic Oscillator 85.70 6.57

Price Performance

Historical Comparison
AGCC
STXS

About AGCC Agencia Comercial Spirits Ltd Class A Ordinary Shares

Agencia Comercial Spirits Ltd specializes in the procurement, distribution, and sale of high-quality whiskies, including both bottled and cask whisky in both Taiwan and international markets. The company's product portfolio includes the distribution of bottled whisky, raw cask whisky, and proprietary brand whisky.

About STXS Stereotaxis Inc.

Stereotaxis Inc is engaged in robotic technologies designed to enhance the treatment of arrhythmias and perform endovascular procedures. The company's mission is the discovery, development, and delivery of robotic systems, instruments, and information solutions for the interventional laboratory. These innovations help physicians provide patient care with robotic precision and safety, improved lab efficiency and productivity, and enhanced integration of procedural information. The company's revenue generation is derived from the streams of Systems; Disposables, Royalty; and Sublease, of which a majority of revenue is generated from the Disposables, service, and accessories stream.

Share on Social Networks: